☰

Xiaofeng Lin, Ph.D. - Publications

Affiliations: 
2005 University of Rhode Island, Providence, RI, United States 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Lin XC, Xu Y, Sun GP, Wen JL, Li N, Zhang YM, Yang ZG, Zhang HT, Dai Y. Molecular dysfunctions in acute myeloid leukemia revealed by integrated analysis of microRNA and transcription factor. International Journal of Oncology. PMID 27082628 DOI: 10.3892/ijo.2016.3489  0.362
2016 Li J, Qin S, Xu J, Xiong J, Wu C, Bai Y, Liu W, Tong J, Liu Y, Xu R, Wang Z, Wang Q, Ouyang X, Yang Y, Ba Y, ... ... Lin X, et al. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 1448-54. PMID 26884585 DOI: 10.1200/JCO.2015.63.5995  0.392
2015 Yang Y, Lu Z, Lin X, Xia C, Sun G, Lian Y, Xu M. Enhancing the bioremediation by harvesting electricity from the heavily contaminated sediments. Bioresource Technology. 179: 615-8. PMID 25549820 DOI: 10.1016/j.biortech.2014.12.034  0.352
2013 Sun G, Lin X, Shen L, Wu F, Xu D, Ruan K, Feng Y. Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 49: 629-36. PMID 23727058 DOI: 10.1016/j.ejps.2013.05.020  0.409
2012 Sun G, Lin X, Hong Y, Feng Y, Ruan K, Xu D. PEGylation for drug delivery to ischemic myocardium: pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 46: 545-52. PMID 22525436 DOI: 10.1016/j.ejps.2012.04.010  0.381
2011 Sun G, Lin X, Zhong H, Yang Y, Qiu X, Ye C, Wu K, Yu M. Pharmacokinetics of pirfenidone after topical administration in rabbit eye. Molecular Vision. 17: 2191-6. PMID 21866212  0.369
2011 Zhong H, Sun G, Lin X, Wu K, Yu M. Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery. Investigative Ophthalmology & Visual Science. 52: 3136-42. PMID 21330661 DOI: 10.1167/iovs.10-6240  0.357
2011 Sun G, Lin X, Wang Z, Feng Y, Xu D, Shen L. PEGylated inulin as long-circulating pharmaceutical carrier. Journal of Biomaterials Science. Polymer Edition. 22: 429-41. PMID 20566038 DOI: 10.1163/092050610X487729  0.423
2010 Sun GL, Lin X. [Mechanisms and strategies for targeting drugs to myocardial ischemic regions]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 45: 827-32. PMID 20931778  0.395
2010 Lin X, Wang S, Jiang Y, Wang ZJ, Sun GL, Xu DS, Feng Y, Shen L. Poly(ethylene glycol)-radix Ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivity. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 76: 230-7. PMID 20633648 DOI: 10.1016/j.ejpb.2010.07.003  0.426
2010 Lin X, Wang Z, Sun G, Shen L, Xu D, Feng Y. A sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of Radix Ophiopogonis polysaccharide in rats. Biomedical Chromatography : Bmc. 24: 820-5. PMID 20020416 DOI: 10.1002/bmc.1369  0.386
2007 Wang YH, Huang K, Lin X, Sun G. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases. Biochemistry. 46: 10162-9. PMID 17691821 DOI: 10.1021/Bi7007257  0.716
2007 Ahmadibeni Y, Hanley M, White M, Ayrapetov M, Lin X, Sun G, Parang K. Metal-binding properties of a dicysteine-containing motif in protein tyrosine kinases. Chembiochem : a European Journal of Chemical Biology. 8: 1592-605. PMID 17674392 DOI: 10.1002/Cbic.200700242  0.743
2007 Ye G, Nam NH, Kumar A, Saleh A, Shenoy DB, Amiji MM, Lin X, Sun G, Parang K. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides. Journal of Medicinal Chemistry. 50: 3604-17. PMID 17580848 DOI: 10.1021/Jm070416O  0.479
2007 Kumar A, Wang Y, Lin X, Sun G, Parang K. Synthesis and evaluation of 3-phenylpyrazolo[3,4-d]pyrimidine-peptide conjugates as Src kinase inhibitors. Chemmedchem. 2: 1346-60. PMID 17530729 DOI: 10.1002/Cmdc.200700074  0.534
2006 Ayrapetov MK, Wang YH, Lin X, Gu X, Parang K, Sun G. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation. The Journal of Biological Chemistry. 281: 23776-84. PMID 16790421 DOI: 10.1074/Jbc.M604219200  0.746
2006 Wang YH, Ayrapetov MK, Lin X, Sun G. A new strategy to produce active human Src from bacteria for biochemical study of its regulation. Biochemical and Biophysical Research Communications. 346: 606-11. PMID 16765913 DOI: 10.1016/J.Bbrc.2006.05.180  0.755
2006 Kumar A, Ye G, Wang Y, Lin X, Sun G, Parang K. Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 49: 3395-401. PMID 16722659 DOI: 10.1021/Jm060334K  0.523
2006 Lin X, Wang Y, Ahmadibeni Y, Parang K, Sun G. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase. Journal of Molecular Biology. 357: 1263-73. PMID 16483606 DOI: 10.1016/J.Jmb.2006.01.046  0.615
2005 Lin X, Ayrapetov MK, Sun G. Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator. Bmc Biochemistry. 6: 25. PMID 16305747 DOI: 10.1186/1471-2091-6-25  0.749
2005 Lin X, Ayrapetov MK, Lee S, Parang K, Sun G. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk. Biochemistry. 44: 1561-7. PMID 15683240 DOI: 10.1021/Bi048142J  0.747
2003 Lee S, Lin X, Nam NH, Parang K, Sun G. Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase. Proceedings of the National Academy of Sciences of the United States of America. 100: 14707-12. PMID 14657361 DOI: 10.1073/Pnas.2534493100  0.59
2003 Lin X, Lee S, Sun G. Functions of the activation loop in Csk protein-tyrosine kinase. The Journal of Biological Chemistry. 278: 24072-7. PMID 12686554 DOI: 10.1074/Jbc.M210596200  0.581
2002 Lee S, Lin X, McMurray J, Sun G. Contribution of an active site cation-pi interaction to the spectroscopic properties and catalytic function of protein tyrosine kinase Csk. Biochemistry. 41: 12107-14. PMID 12356311 DOI: 10.1021/Bi026439G  0.589
Show low-probability matches.